Le Lézard
Classified in: Health
Subjects: PER, MAT

Planned Parenthood of Greater New York Announces Expansion of its Executive Leadership Team


The new Executive Leadership Team reflects the growing demand for PPGNY services and the organization's ability to attract new and highly skilled talent.

NEW YORK, April 27, 2022 /PRNewswire/ -- Planned Parenthood of Greater New York (PPGNY), a leading provider of sexual and reproductive health care, education, and advocacy, today announces the expansion of its Executive Leadership Team with new hires to critical leadership positions. The expansion of PPGNY's Executive Leadership Team reflects the growing demand for PPGNY services and the organization's ability to attract new and highly skilled talent to a workforce of more than 580 employees across 65% of New York State.

Planned Parenthood of Greater New York welcomes:

"As more states roll back access to sexual and reproductive health care, we know more people will turn to Planned Parenthood of Greater New York for compassionate, affordable services," said Joy D. Calloway, Interim President & CEO of Planned Parenthood of Greater New York. "Leaders of this high caliber position us to enhance our operations and meet the growing demand for quality health care. We are confident in our progress toward a future where PPGNY is a beacon for access to sexual and reproductive health services, which will always include safe, legal abortion."

These new executive leaders will join a well-established leadership team that has steered PPGNY since its launch in 2020?including Joy D. Calloway, Interim President & CEO; Lisa Williams, Chief of Staff; Keith Corso, Chief Development Officer; and Rosalba Messina, Chief Financial Officer.

Contact: Jacquelyn Marrero, [email protected], 646-642-6682

SOURCE Planned Parenthood of Greater New York


These press releases may also interest you

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: